Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Terry Day and Evan Graboyes.
Connection Strength

6.791
  1. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.697
  2. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.631
  3. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.610
  4. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.608
  5. A pilot randomized controlled trial to evaluate a survivorship care planning intervention for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2022 Jun 27.
    View in: PubMed
    Score: 0.220
  6. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.202
  7. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.201
  8. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.198
  9. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.194
  10. The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020. Cancers (Basel). 2020 Jun 11; 12(6).
    View in: PubMed
    Score: 0.191
  11. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.191
  12. Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
    View in: PubMed
    Score: 0.190
  13. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
    View in: PubMed
    Score: 0.190
  14. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.188
  15. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.186
  16. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.176
  17. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Prospective Cohort Pilot Study. Otolaryngol Head Neck Surg. 2019 07; 161(1):105-110.
    View in: PubMed
    Score: 0.175
  18. A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 06; 160(6):941-954.
    View in: PubMed
    Score: 0.175
  19. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.174
  20. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.172
  21. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
    View in: PubMed
    Score: 0.167
  22. Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
    View in: PubMed
    Score: 0.166
  23. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.163
  24. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.161
  25. Risk Factors Associated With Unplanned Readmission in Patients Undergoing Parotid Cancer Surgery: A Study of the National Cancer Database. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):544-50.
    View in: PubMed
    Score: 0.145
  26. Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression. Head Neck. 2022 07; 44(7):1520-1527.
    View in: PubMed
    Score: 0.054
  27. Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study. Front Oncol. 2021; 11:808465.
    View in: PubMed
    Score: 0.053
  28. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.053
  29. Free Flap Inset Techniques in Salvage Laryngopharyngectomy Repair: Impact on Fistula Formation and Function. Laryngoscope. 2021 03; 131(3):E875-E881.
    View in: PubMed
    Score: 0.049
  30. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.045
  31. Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
    View in: PubMed
    Score: 0.044
  32. Factors associated with gastrostomy tube dependence following salvage total laryngectomy with microvascular free tissue transfer. Head Neck. 2019 04; 41(4):865-870.
    View in: PubMed
    Score: 0.043
  33. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.041
  34. Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.